Featured Jobs
|
Great Lakes Pension Associates, Inc.
|
|
Senior Specialist 401k Recordkeeping T Bank N.A.
|
|
Retirement Planners and Administrators (RPA)
|
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
|
Pollard & Associates
|
|
Defined Contributions Compliance Consultant Loren D. Stark Company (LDSCO)
|
|
New York City District Council of Carpenters Benefit Funds
|
|
TPA Retirement Plan Consultant EPIC RPS (TPA/DPS)
|
|
Fringe Benefit Group
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
Defined Benefit Consultant/Enrolled Actuary Pension Plan Specialists, PC
|
|
Retirement Solutions Specialists
|
|
Greenline Wealth Management
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Best Practices for Managing Costs of Orphan Drugs (PDF)
Archimedes, via Chelko Center for Benefits Management 
May 25, 2017 "The overarching 'best practice' management approach for specialty drugs in the medical benefit is to: [1] pay only reasonable costs for drugs, administration, and related fees; and [2] pay only for drugs that are clinically appropriate for the patient.... [T]hese 'simple' objectives aren't easy to carry out for specialty drugs administered in medical sites of care for two reasons.... First, medical claims may be billed with limited information.... Second, drug pricing in the medical benefit is highly, and inappropriately, variable." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |
